Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacques Morel

Showing results (131-140 of 165) with videos related to

Pageof 17
Sort By:
La Revue De Medecine Interne|November 5, 2024
Use of immunosuppressants and biologics in giant cell arteritis: Recommendations of the French Study Group for Large Vessel Vasculitis (GEFA)Hubert de Boysson, Valérie Devauchelle-Pensec, Christian Agard, et al.
RMD Open|July 5, 2025
Adaptive immune responses to SARS-CoV-2 in DMARD-treated patients with chronic inflammatory rheumatismsMaxime Beretta, Emmanuel Martin, Olivier Fogel, et al.
La Revue De Medecine Interne|November 1, 2024
French protocol for the diagnosis and management of giant cell arteritisHubert de Boysson, Valérie Devauchelle-Pensec, Christian Agard, et al.
Annals of Internal Medicine|April 15, 2014
Treatment of primary Sjögren syndrome with rituximab: a randomized trialValérie Devauchelle-Pensec, Xavier Mariette, Sandrine Jousse-Joulin, et al.
Annals of the Rheumatic Diseases|August 21, 2017
Spectrum of lymphomas across different drug treatment groups in rheumatoid arthritis: a European registries collaborative projectLouise K Mercer, Anne C Regierer, Xavier Mariette, et al.
JAMA|July 17, 2014
Effects of hydroxychloroquine on symptomatic improvement in primary Sjögren syndrome: the JOQUER randomized clinical trialJacques-Eric Gottenberg, Philippe Ravaud, Xavier Puéchal, et al.
The Lancet. Rheumatology|March 4, 2024
Identification of distinct subgroups of Sjögren's disease by cluster analysis based on clinical and biological manifestations: data from the cross-sectional Paris-Saclay and the prospective ASSESS cohortsYann Nguyen, Gaëtane Nocturne, Julien Henry, et al.
Arthritis Care & Research|July 9, 2016
Severe Health-Related Quality of Life Impairment in Active Primary Sjögren's Syndrome and Patient-Reported Outcomes: Data From a Large Therapeutic TrialDivi Cornec, Valérie Devauchelle-Pensec, Xavier Mariette, et al.
Rheumatology (Oxford, England)|November 22, 2024
Do SMS/e-mail reminders increase influenza vaccination of rheumatoid arthritis patients under anti-TNF: a nested randomized controlled trial in the ART e-cohortYann Nguyen, Gabriel Baron, Naima Hamamouche, et al.
Clinical and Experimental Rheumatology|October 22, 2024
Comparison of SARS-COV-2 humoral response between rheumatoid arthritis, psoriatic arthritis and spondyloarthritis patients and controls in two unvaccinated cohortsAdeline Ruyssen-Witrand, Chloé Dimeglio, Erika Nogue, et al.
Pageof 17

Showing results (131-140 of 165) with videos related to

Sort By:
Pageof 17
La Revue De Medecine Interne|November 5, 2024
Use of immunosuppressants and biologics in giant cell arteritis: Recommendations of the French Study Group for Large Vessel Vasculitis (GEFA)Hubert de Boysson, Valérie Devauchelle-Pensec, Christian Agard, et al.
RMD Open|July 5, 2025
Adaptive immune responses to SARS-CoV-2 in DMARD-treated patients with chronic inflammatory rheumatismsMaxime Beretta, Emmanuel Martin, Olivier Fogel, et al.
La Revue De Medecine Interne|November 1, 2024
French protocol for the diagnosis and management of giant cell arteritisHubert de Boysson, Valérie Devauchelle-Pensec, Christian Agard, et al.
Annals of Internal Medicine|April 15, 2014
Treatment of primary Sjögren syndrome with rituximab: a randomized trialValérie Devauchelle-Pensec, Xavier Mariette, Sandrine Jousse-Joulin, et al.
Annals of the Rheumatic Diseases|August 21, 2017
Spectrum of lymphomas across different drug treatment groups in rheumatoid arthritis: a European registries collaborative projectLouise K Mercer, Anne C Regierer, Xavier Mariette, et al.
JAMA|July 17, 2014
Effects of hydroxychloroquine on symptomatic improvement in primary Sjögren syndrome: the JOQUER randomized clinical trialJacques-Eric Gottenberg, Philippe Ravaud, Xavier Puéchal, et al.
The Lancet. Rheumatology|March 4, 2024
Identification of distinct subgroups of Sjögren's disease by cluster analysis based on clinical and biological manifestations: data from the cross-sectional Paris-Saclay and the prospective ASSESS cohortsYann Nguyen, Gaëtane Nocturne, Julien Henry, et al.
Arthritis Care & Research|July 9, 2016
Severe Health-Related Quality of Life Impairment in Active Primary Sjögren's Syndrome and Patient-Reported Outcomes: Data From a Large Therapeutic TrialDivi Cornec, Valérie Devauchelle-Pensec, Xavier Mariette, et al.
Rheumatology (Oxford, England)|November 22, 2024
Do SMS/e-mail reminders increase influenza vaccination of rheumatoid arthritis patients under anti-TNF: a nested randomized controlled trial in the ART e-cohortYann Nguyen, Gabriel Baron, Naima Hamamouche, et al.
Clinical and Experimental Rheumatology|October 22, 2024
Comparison of SARS-COV-2 humoral response between rheumatoid arthritis, psoriatic arthritis and spondyloarthritis patients and controls in two unvaccinated cohortsAdeline Ruyssen-Witrand, Chloé Dimeglio, Erika Nogue, et al.
Pageof 17